MSA
ARIA

Mason Street Advisors’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Mason Street Advisors’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-21,130
Closed -$170K – 1926
2014
Q1 		$170K Sell
21,130
-650
-3% -$5.06K ﹤0.01% 1487
2013
Q4 		$149K Sell
21,780
-540
-2% -$2.92K ﹤0.01% 1603
2013
Q3 		$411K Sell
22,320
-13,470
-38% -$262K ﹤0.01% 1157
2013
Q2 		$626K Buy
+35,790
New +$634K 0.01% 1032

Other funds holding ARIA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Mason Street Advisors's ARIA Position: Q2 2014 in Review

Mason Street Advisors sold out of Ariad Pharmaceuticals Inc (ARIA) in Q2 2014, closing a stake of 21,130 shares — an estimated $170K sold.

Mason Street Advisors first reported a position in ARIA in Q2 2013 and held it in 4 quarters. The position peaked at $626K in Q2 2013. 169 funds tracked by Wall St. Rank hold ARIA as of Q2 2014.

  • Mason Street Advisors reported no remaining Ariad Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Mason Street Advisors sold 21,130 Ariad Pharmaceuticals Inc shares in Q2 2014, an estimated $170K.
  • Mason Street Advisors first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 4 quarters.
  • Mason Street Advisors's Ariad Pharmaceuticals Inc position peaked at $626K in Q2 2013.
  • 169 funds tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q2 2014.

Based on Mason Street Advisors's 13F filing for Q2 2014, filed 5 Aug 2014.